Hubei Jumpcan Pharmaceutical Co., Ltd
600566Pharmaceuticals
CN¥26.88+0.64%As of Oct 29vs prior close
- Market cap
- $3.7B
- P/E (TTM)
- 13.4×
- From 52W high
- −7.15%
- EPS (LTM)
- CN¥2.00
- Revenue (LTM)
- CN¥5.8B
- Net margin
- 31.69%
Nomior Score
51
Steady ProfileTop 48% of the scored universe
Growth46
Quality55
Value51
Momentum48
Resilience58
Growth
−11.58%revenue a year over 3 fiscal years
YE22 CN¥9BLTM CN¥5.8B
Connections
Revenue to profitYE25
29% of revenue became net profit, down 3 pts on a year.